Back to School: How biopharma can reboot drug development. Access exclusive analysis here

1013 QTs
BioCentury & Getty Images

Finance

Oct. 13 Quick Takes: Sovereign wealth fund backs Evotec; plus Canaan, EdiGene, Cedilla, Rappta and Lassogen

Oct 13, 2020 | 10:56 PM GMT

UAE fund, Novo invest €250M in Evotec
Evotec

Read the full 376 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE